Skip to main content
Figure 5 | BMC Pharmacology

Figure 5

From: Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysis

Figure 5

Functional characterisation of LE404 (■) and LE410 () at hD 1 (A, B, C) and hD 2L receptors (D, E, F). A Inhibition by LE404 and LE410 of 100 nM SKF38393-stimulated accumulation of intracellular [cAMP]. Data shown are means ± SEM of at least four determinations assayed in triplicate. B Inhibition by LE404 and LE410 of 100 nM SKF38393-stimulated increase in intracellular [Ca2+]. Data shown are means ± SEM of at least four determinations assayed in triplicate. C Inhibition by LE404 and LE410 of G-protein activation obtained by 1 μM dihydrexidine-stimulation. Data shown are means ± SEM of two independent experiments assayed in duplicate. D Inhibition by LE404 and LE410 of 100 nM quinpirole-stimulated decrease of intracellular [cAMP] in the presence of 10 μM forskolin. Data shown are means ± SEM of at least four determinations assayed in triplicate. E Inhibition by LE404 and LE410 of 30 nM quinpirole-stimulated increase in intracellular [Ca2+]. Data shown are means ± SEM of at least four determinations assayed in triplicate. F Inhibition by LE404 and LE410 of G-protein activation obtained by 10 μM quinpirole-stimulation. Data shown are means of two independent experiments assayed in duplicate.

Back to article page